Using magnetic stimulation to treat headaches after concussions
Official title: Using Repetitive Transcranial Magnetic Stimulation to Manage Headaches and Improve Rehabilitation Outcomes in Mild Traumatic Brain Injury: A Longitudinal Study
Run by State University of New York - Upstate Medical University · NCT06112093 · Data updated 2026-11-12
This study is testing if a special type of brain stimulation can help people with chronic headaches after a concussion feel better without the side effects of regular medications.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 55 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | State University of New York - Upstate Medical University Academic / other |
| Locations | 1 site (Syracuse, New York) |
| Status | Recruiting |
| Started | October 23, 2023 |
| Main results expected | October 23, 2026 |
| Study ends | October 23, 2027 |
| Registry record updated | October 10, 2025 |
| Trial ID | NCT06112093 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-55 who have experienced a mild traumatic brain injury and have persistent headaches that developed within a week of the injury.
✕Probably not a fit
Patients with a history of chronic headache disorders prior to their concussion may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study examines the long-term effects of repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, on chronic headaches that follow mild traumatic brain injury (mTBI). The approach aims to reduce headache symptoms without the side effects associated with traditional medications. Participants will receive either active rTMS or a sham treatment to assess the effectiveness of this intervention. The study also seeks to identify biomarkers that could aid in the diagnosis and prognosis of post-concussion symptoms.
Why it matters
Potential benefit: If successful, this treatment could significantly alleviate chronic headaches in patients recovering from concussions, improving their quality of life.
How similar studies have gone: Other studies have shown promising results with rTMS for headache management, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 - 55 years old * mTBI with loss of consciousness for less than 30 min, initial Glasgow Coma Scale between 13 and 15, or post-traumatic amnesia for ≤ 24 hours * diagnosis of persistent post-traumatic headache according to the International Classification of Headache Disorders, 3rd edition (ICHD-3) criteria * headache develops within 7 days after head trauma * headache persists for \>=3 months after head trauma despite receiving standard care * average persistent headache intensity is \>= 3/10 of the numerical rating scale (NRS) on \>=3days/week * no evidence of radiculopathy or peripheral neuropathy on electromyography or clinical evaluation * no evidence of other possible causes of headaches Exclusion Criteria: * history of chronic headache diagnoses such as migraine, tension, or cluster headaches prior to the incidence of mTBI * history of other neurologic conditions with medications affecting the central nervous system * contraindications of receiving TMS (e.g., a history of epileptic seizure and having implants like a cardiac pacemaker or intracerebral vascular clip
Where it's running
-
SUNY Upstate Medical University
Syracuse, New York, United States Recruiting
Study contacts
- Principal investigator: Yi-Ling Kuo, PT, PhD — State University of New York - Upstate Medical University
- Study coordinator: Yi-Ling Kuo, PT, PhD
- Email: kuoy@upstate.edu
- Phone: 3154646911
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Concussion recovery and support program for young adults
This pilot randomized trial will test whether a six-session online therapy called CRISP helps 18–30-year-olds with concussion-related headaches feel and function better.
-
Improving attention in military personnel with mild traumatic brain injury using brain stimulation and cognitive training
This study is testing a new way to help Active Duty Service Members and Veterans with mild traumatic brain injury improve their attention by combining brain stimulation with cognitive training.
-
Personalized brain stimulation for long-term symptoms after concussion
This study will try personalized, noninvasive brain stimulation (TMS) to reduce dizziness, headaches, memory problems, and other lasting symptoms in adults aged 18–65 after a concussion.
-
Brain stimulation and imaging for children with mild traumatic brain injury
This study is testing if a type of brain stimulation can help children aged 10-15 recover better from mild traumatic brain injuries by improving their thinking and movement skills.
-
Digital intervention for post-concussion symptoms
This study is testing a new digital program called GAIN Lite to see if it helps adults with ongoing concussion symptoms feel better compared to regular care.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.